Compliance with hormone replacement therapy among Swedish women

International Nursing Review

Volumn 48, Issue 4, 2001, Pages 224-232

  Berterö, Carina ^a,b   Johansson, G ^a  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Climacteric symptoms; Compliance; Hormone Replacement Therapy

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; CLIMACTERIUM; FEMALE; HORMONE SUBSTITUTION; HUMAN; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SWEDEN;

ADULT; AGED; ATTITUDE; CLIMACTERIC; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; RISK FACTORS; SWEDEN;

EID: 0035754695     PISSN: 00208132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1466-7657.2001.00089.x     Document Type: Article

References (41)

1. Andersson, K., et al. (1992) Intrauterine Release of Levongestrel, a New Way of Adding Progestogen in Hormone Replacement Therapy. Obstetrics and Gynecology, 79, 963-967.
2. Aronson, J.K. & Hardman, M. (1992) ABC of Monitoring Drug Therapy. Patient Compliance. British Journal of Medicine, 305, 1009-1011.
3. Berg, G., et al. (1988) Climacteric Symptoms Among Women Aged 60-62 in Linköping, Sweden in 1986. Maturitas, 10, 193-199.
4. Bäckström, T. (1995) Symptoms Related to the Menopause and Sex Steroid Treatments. In Non-Reproductive Actions of Sex Steroids. Ciba Foundation Symposium 191. Wiley, Chichester, pp. 171-186.
5. Dennerstein, L., et al. (1980) Hormones and Sexuality: Effects of Oestrogen and Progestogen. Obstetrics and Gynecology, 56, 316-322.
6. Enzelberger, H., et al. (1991) Zur Wirksamkeit Einer Intravaginalen Ostrioltablettenapplikation Bei Frauen Mit Urge-Inkontinenz [in German]. Geburtshilfe Frauenheilkd, 51, 834-838.
7. FASS. FASS Läkemedelsinformation [in Swedish] (1999) Linfo Läkemedelsinformation, Stockholm.
8. Geola, F.L., et al. (1980) Biological Effects of Various Doses of Conjugated Equine Oestrogen in Postmenopausal Women. Journal of Clinical Endocrine Metabolism, 51, 620-625.
9. Hailes, J.D., et al. (1981) Conjugated Equine Oestrogen Versus Placebo in the Management of Menopausal Symptoms. The Medical Journal of Australia, 3, 340-342.
10. Hammar, M., et al. (1984) Climacteric Symptoms in an Unselected Sample of Swedish Women. Maturitas, 6, 345-350.
11. Hammarbäck, S., et al. (1985) Cyclic Mood Changes as in Premenopausal Syndrome During Sequential Oestrogen Postmenopausal Replacement Therapy. Acta Obstetrics and Gynecology Scandiavica, 64, 393-397.
12. Holte, A. (1992) Influences of Natural Menopause on Health Complaints: a Prospective Study on Healthy Norwegian Women. Maturitas, 14, 127-141.
13. Hulka, B., et al. (1980) Estrogen and Endometrial Cancer. American Journal of Obstetrics and Gynecology, 137, 92.
14. Hulka, B.S., et al. (1982) Breast Cancer and Oestrogen Replacement Therapy. American Journal of Obstetrics and Gynecology, 143, 638-644.
15. Hulka, B.S., et al. (1994) Steroid Hormones and Risk of Breast Cancer. Cancer Supplement, 74, 1111-1124.
16. Hunt, K., et al. (1987) Long-Term Surveillance of Mortality and Cancer Incidence in Women Receiving Hormone Replacement Therapy. British Journal of Obstetrics and Gynaecology, 99 (4), 620-635.
17. Iosif, C.S. & Bekassy, Z. (1984) Prevalence of Genitourinary Symptoms in the Late Menopause. Acta Obstetrica Gynecologica Scandivica, 63, 257-260.
18. Jaszman, L. (1976) Epidemiology of the Climacteric Syndrome. In The Management of the Menopause and Postmenopausal Years (Campell, S., ed.). MTP Press, Lancaster, pp. 11-23.
19. Kaufert, P.A., et al. (1992) The Manitoba Project: a ReExamination of the Link Between Menopause and Depression. Maturitas, 14, 143-155.
20. Landgren, B.-M. & Collins, A. (1994) Finns Det Ett Menopausalt Syndrom? [in Swedish] Läkartidningen, 23, 216-218.
21. La Vecchia, C., et al. (1986) Non-Contraceptive Oestrogens and the Risk of Breast Cancer in Women. International Journal of Cancer, 38, 835-858.
22. Lassen, L. (1989) Compliance I Almen Praksis [in Danish]. Istitute for almen medicin, Köpenhamn.
23. Mabeck, C.E. (1995) Läkaren Och Patienten [in Swedish]. Bonniers, Stockholm.
24. Mertens, T.E. (1993) Estimating the Effects of Misclassification. Lancet, 342, 418-421.
25. Mills, P.K., et al. (1989) Prospective Study of Exogenous Hormone Use and Breast Cancer in Seventh-Day Adventists. Cancer, 64, 591-597.
26. Nappi, C., et al. (1991) The Effect of Various Drugs with Neuroendocrine Activity and Transdermal Estradiol on Plasma Gonadotropin Concentration After Ovariectomy in Reproductive-Aged Women. Acta Obstetrics and Gynecology Scandinavian, 70, 435-439.
27. Nathorts-Böös, J., et al. (1993) Is Sexual Life Influenced by Transdermal Oestrogen Therapy? Acta Obstetrics and Gynecology Scandinavica 72, 656-600.
28. Oakley, A. & Hoods, S. (1990) Helpers in Childbirth Midwifery Today. Hemisphere Publications, New York.
29. Orlander, J.D., et al. (1992) Urinary Tract Infections and Oestrogen Use in Older Women. Journal of American Geriatrics Society, 40, 817-820.
30. Paganini-Hill, A., et al. (1989) Endometrial Cancer and Patterns of Use of Oestrogen Replacement Therapy: a Cohort Study. Breast Cancer, 59, 445-447.
31. Plunkett, E. & Wolfe, B. (1992) Prolonged Effects of a Novel, Low-Dosage Continuous Progestin-Cyclic Oestrogen Replacement Program in Postmenopausal Women. American Journal of Obstetrics and Gynecology, 167, 117-121.
32. Roux, C. (1997) Estrogen Therapy in Postmenopausal Osteoporosis. What We Know and What We Don't. Reveu-Du-Rhumatisme [English Edition, June], 64, 402-409.
33. Samsioe, G., et al. (1985) Occurrence, Nature and Treatment of Urinary Incontinence in a 70-Year Old Female Population. Maturitas, 7, 335-342.
34. Socialstyrelsen (The National Board of Health and Welfare) (1981) Allmänna Råd Från Socialstyrelsen 1981: 4. Hälsovård För Mödrar Och Barn Inom Primärvården [in Swedish]. Socialstyrelsen, Stockholm.
35. Socialstyrelsen (The National Board of Health and Welfare) (1997) Hälsovård För, Under Och Efter Graviditet [in Swedish]. Socialstyrelsen, Stockholm.
36. Socialstyrelsen (The National Board of Health and Welfare) (1998) Sos Allmänna Råd 1995: 1 Författningshandbok [in Swedish]. Almqvist & Wiksell, Uppsala.
37. Whitehead, M.I. & Goodfree, V. (1992) Hormone Replacement Therapy. Your Questions Answered. Churchill Livingstone, London.
38. Wiklund, I., et al. (1993) Quality of Life of Postmenopausal Women on a Regime of Transdermal Estradiol Therapy: a Double Blind Placebo-Controlled Study. American Journal of Obstetrics and Gynecology, 168, 824-830.
39. Willis, D.B., et al. (1996) Oestrogen Replacement Therapy and Risk of Fatal Breast Cancer in a Prospective Cohort of Menopausal Women in the United States. Cancer Causes and Control, 7, 449-457.
40. Weinstein, L., et al. (1990) Evaluation of a Continuous Combined Low-Dose Regimen of Oestrogen-Progestin for Treatment of the Menopausal Patient. American Journal of Obstetrics and Gynecology, 162, 1534-1542.
41. Wren, B.G. & Brown, L. (1990) Compliance with Hormonal Replacement Therapy. Maturitas, 13, 17-21.